U080 “Bread n’ Butter with a Side of Nutella”: Short n’ Sweet, High-Yield Updates on Management of Bread n’ Butter Dermatologic Diseases
DESCRIPTION
In this fast-paced, high-impact session, our expert team delivers “Short n’ Sweet” updates on the bread-and-butter dermatologic conditions you encounter every day. Each update is loaded with practical, evidence-based insights you can start using in clinic tomorrow — sure to impress colleagues, trainees, and patients alike. Whether you’re in training, private practice, or academic medicine, these clinical pearls will sharpen your decision-making and elevate your everyday care. No time to keep up with the latest derm evidence? Let us do the heavy lifting for you.
LEARNING OBJECTIVES
Summarize real-world database and comparative effectiveness research on current treatments for common dermatologic diseases and specific disease phenotypes
Summarize key updates on new, existing, and upcoming treatments for common dermatologic diseases — delivering practical insights that matter to trainees, community clinicians, and academic dermatologists alike.
Diagnose and treat common dermatologic diseases using cutting-edge advances— with real-world applications for trainees, practicing dermatologists, and academic experts alike.
SCHEDULE
7:30 AM
Root Awakening: The Latest in Hair Loss
Kathie Pei Huang, MD, FAAD
7:40 AM
Field Goals: High Yield Updates in Actinic Keratosis and Keratinocyte Carcinoma Preventation
Lindsey Voller, MD, FAAD
7:50 AM
GLP1 in Dermatology: What’s New and What’s Next
Corey J. Georgesen, MD, FAAD
8:00 AM
Hidradenitis Suppurativa: What’s New and What’s Next
Vishnu Harikumar, MD, FAAD
8:10 AM
Pyoderma Gangrenosum: New Insights and Evolving Treatments
Brian Simmons, MD, FAAD
8:20 AM
Supportive Oncodermatology: What’s New and What’s Next
Jesse Philip Hirner, MD, FAAD
DIRECTOR
Erin Barrett, MD, MBA, FAAD
University of North Dakota School of Medicine and Health Science & Sanford-Fargo
SPEAKERS
Corey J. Georgesen, MD, FAAD
Vishnu Harikumar, MD, FAAD
Sanford Health
Jesse Philip Hirner, MD, FAAD
Kathie Pei Huang, MD, FAAD
Brian Simmons, MD, FAAD
Dartmouth Gisel School of Medicine
Lindsey Voller, MD, FAAD
DISCLOSURES
Erin Barrett, MD, MBA, FAAD
Eli Lilly – Investigator(No Compensation Received); Guidepoint Global, LLC – Other(Fees); Regeneron – Advisory Board(Honoraria); Sanofi – Advisory Board(Honoraria), Investigator(No Compensation Received); Sanofi Speaker Programs – Speaker/Faculty Education(Honoraria); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria); UCB Pharma – Advisory Board(Honoraria);
Corey J. Georgesen, MD, FAAD
No financial relationships exist with ineligible companies.
Vishnu Harikumar, MD, FAAD
No financial relationships exist with ineligible companies.
Jesse Philip Hirner, MD, FAAD
Abbvie – Speaker(Honoraria);
Kathie Pei Huang, MD, FAAD
AbbVie – Consultant (1099 relationship)(Fees); IQVIA Solutions Australia Pty Ltd – Other(Fees);
Brian Simmons, MD, FAAD
AbbVie – Investigator(No Compensation Received); Acelyrin – Investigator(No Compensation Received); Arcutis Biotherapeutics – Investigator(No Compensation Received); argenx – Investigator(Honoraria); Biofrontera – Investigator(No Compensation Received); Boehringer Ingelheim – Investigator(No Compensation Received); Eli Lilly – Investigator(No Compensation Received); Insmed Incorporated – Investigator(No Compensation Received); Pfizer Inc. – Advisory Board(Honoraria); Priovant Therapeutics – Investigator(No Compensation Received); Smart Practice – Investigator(No Compensation Received); Takeda Pharmaceuticals USA Inc – Investigator(No Compensation Received);
Lindsey Voller, MD, FAAD
No financial relationships exist with ineligible companies.